SubSUF-ER - Management of moderate to severe monotraumatic pain with sublingual Sufentanil in an emergency situation.
Date de révision : 24/04/2026
300 participants
Homme Femme
A partir de 18 ans
Date de début de recrutement : 21/04/2025
Critères :
Critères d'inclusion :
- adult patient
- Patient with a numeric pain rating scale ≥ 4
- Pain of monotraumatic origin in the upper or lower limb
- Glasgow = 15
- SaO2 > 95% in ambient air
Critères d'exclusion :
- Polytrauma
- Patient under guardianship, curatorship, deprived of liberty or under legal protection
- Patient does not speak or read French
- Analgesic treatment within 4 hours prior to admission (except paracetamol)
- Woman of childbearing age not using effective contraception, or declaring herself pregnant or at risk of pregnancy or breastfeeding woman, or positive pregnancy test upon inclusion
- Patient requiring intravenous line placement upon admission
- Contraindication or allergy to one of the molecules in the analgesic protocol
- Refusal to participate
- Known drug abuse or psychiatric disorders
- Known oxygen dependency or COPD
- Not affiliated with social security
Lieux et contacts
Informations pratiques pour participer à cet essai.
Sites des essais
Adresse
University Hospital Of Clermont-Ferrand
63003 Clermont Ferrand Cedex 1 France
Comment postuler ?
Pour participer à cet essai clinique, veuillez contacter la personne responsable de l'étude. Vous trouverez ses coordonnées dans la section "Lieux et contacts", puis "Contacts".